|
|
| 20.36 Data as of Mar 14 |  +0.01 / +0.05%Today’s Change | 18.46 Today|||52-Week Range 28.42 | -16.14% Year-to-Date |
| Previous close | 20.35 |
| Today’s open | 20.30 |
| Day’s range | 20.10 - 20.85 |
| Volume | 328,417 |
| Average volume (3 months) | 446,100 |
| Market cap | $443.8M |
| Dividend yield | -- |
| Earnings growth (last year) | +43.59% |
| Earnings growth (this year) | +57.95% |
| Earnings growth (next 5 years) | +35.00% |
| Revenue growth (last year) | -5.30% |
| P/E ratio | NM |
| Price/Sales | 6.52 |
| Price/Book | 2.57 |
| Today’s change | Today’s % change | |
|---|---|---|
| BDSIBioDelivery Sciences... | -0.13 | -1.44% |
| DNDNDendreon Corp | +0.03 | +1.01% |
| OXFDOxford Immunotec Glo... | -0.76 | -3.13% |
| ALRPRBAlere Inc | +0.87 | +0.29% |
| Next reporting date | April 29, 2014 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $80.9M |
| Annual profit (last year) | -$9.6M |
| Net profit margin | -11.88% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director William K. Heiden |
Chief Operating Officer & Executive Vice President Frank E. Thomas |
Corporate headquarters Lexington, Massachusetts |
.
